Vergleichende Darstellung bisheriger ökonomischer Evaluationsstudien zum Screening auf Phenylketonurie

D. Ahrens; B. Güntert; A. Brand

Vergleichende Darstellung bisheriger ökonomischer Evaluationsstudien zum Screening auf Phenylketonurie

Translated title of the contribution: Comparative presentation of economic evaluation studies of phenylketoneuria screening

D. Ahrens^*
, B. Güntert
, A. Brand

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

A systematic review was undertaken to assess the economic value of PKU screening in the framework of newborn screening for inborn errors of metabolism. Therefore, seven international studies on this topic were connected and examined with regard to differences and similarities. The relation between costs and benefits of PKU-screening programmes goes from 1:1,2 up to 1:9,25. The differences can be explained by varying incidence of PKU (in international comparison) and particularly by methodical differences in the respective study designs. This aspect is pointed out while taking up and emphasising the necessity of standardisation in economic evaluation studies. Furthermore, future developments (chances, trends, changes) in newborn screening are discussed, based on the potential use of new technologies.

Translated title of the contribution	Comparative presentation of economic evaluation studies of phenylketoneuria screening
Original language	German
Pages (from-to)	190-196
Number of pages	7
Journal	Gesundheitswesen
Volume	61
Issue number	4
Publication status	Published - 01-12-1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Public Health, Environmental and Occupational Health

Cite this

@article{54d3d904541b46e3a19e76dcbafd5cbc,

title = "Vergleichende Darstellung bisheriger {\"o}konomischer Evaluationsstudien zum Screening auf Phenylketonurie",

abstract = "A systematic review was undertaken to assess the economic value of PKU screening in the framework of newborn screening for inborn errors of metabolism. Therefore, seven international studies on this topic were connected and examined with regard to differences and similarities. The relation between costs and benefits of PKU-screening programmes goes from 1:1,2 up to 1:9,25. The differences can be explained by varying incidence of PKU (in international comparison) and particularly by methodical differences in the respective study designs. This aspect is pointed out while taking up and emphasising the necessity of standardisation in economic evaluation studies. Furthermore, future developments (chances, trends, changes) in newborn screening are discussed, based on the potential use of new technologies.",

author = "D. Ahrens and B. G{\"u}ntert and A. Brand",

year = "1999",

month = dec,

day = "1",

language = "German",

volume = "61",

pages = "190--196",

journal = "Gesundheitswesen",

issn = "0941-3790",

publisher = "Georg Thieme Verlag",

number = "4",

}

TY - JOUR

T1 - Vergleichende Darstellung bisheriger ökonomischer Evaluationsstudien zum Screening auf Phenylketonurie

AU - Ahrens, D.

AU - Güntert, B.

AU - Brand, A.

PY - 1999/12/1

Y1 - 1999/12/1

N2 - A systematic review was undertaken to assess the economic value of PKU screening in the framework of newborn screening for inborn errors of metabolism. Therefore, seven international studies on this topic were connected and examined with regard to differences and similarities. The relation between costs and benefits of PKU-screening programmes goes from 1:1,2 up to 1:9,25. The differences can be explained by varying incidence of PKU (in international comparison) and particularly by methodical differences in the respective study designs. This aspect is pointed out while taking up and emphasising the necessity of standardisation in economic evaluation studies. Furthermore, future developments (chances, trends, changes) in newborn screening are discussed, based on the potential use of new technologies.

AB - A systematic review was undertaken to assess the economic value of PKU screening in the framework of newborn screening for inborn errors of metabolism. Therefore, seven international studies on this topic were connected and examined with regard to differences and similarities. The relation between costs and benefits of PKU-screening programmes goes from 1:1,2 up to 1:9,25. The differences can be explained by varying incidence of PKU (in international comparison) and particularly by methodical differences in the respective study designs. This aspect is pointed out while taking up and emphasising the necessity of standardisation in economic evaluation studies. Furthermore, future developments (chances, trends, changes) in newborn screening are discussed, based on the potential use of new technologies.

UR - https://www.scopus.com/pages/publications/0033110101

UR - https://www.scopus.com/pages/publications/0033110101#tab=citedBy

M3 - Article

C2 - 10408146

AN - SCOPUS:0033110101

SN - 0941-3790

VL - 61

SP - 190

EP - 196

JO - Gesundheitswesen

JF - Gesundheitswesen

IS - 4

ER -

Vergleichende Darstellung bisheriger ökonomischer Evaluationsstudien zum Screening auf Phenylketonurie

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this